Date: February 11, 2026 Source: Cochrane Summary: Three major reviews commissioned by the World Health Organization find that GLP-1 drugs including tirzepatide (sold as Mounjaro and Zepbound), semaglutide (Ozempic and Wegovy), and liraglutide (Victoza and Saxenda) can lead to substantial weight loss in people with obesity
If an antidepressant appears to be contributing to poor glycaemic control or weight gain, a discussion with a psychiatrist or GP about alternative options may be appropriate
It supports blood sugar regulation, promotes satiety, and aids weight loss by mimicking hormones that boost insulin release
Even though it is pretty expensive, glutathione injections are quite popular as they significantly increase the bioavailability of glutathione
So, 20 units would be 3mg
Overdose occurs when patients take more than their prescribed dose and frequency